Chester County Eye Care provides comprehensive eye care services, including cataract, glaucoma, LASIK, and retinal treatments. The practice is staffed by board-certified ophthalmologists and optometrists.

Chester County Eye Care

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Shwen Gwee

Johann Rudolf

Joerg Reinhardt

Alexander Clavel

Novartis AG

RetinAI is a technology company that specializes in creating a data management platform integrated with AI modules, designed to improve understanding of patients' diseases and outcomes through enhanced insights and knowledge.

Metric
Company Name	Chester County Eye Care	Novartis AG	RetinAI
Symbol		NOVN
MSH ID	COM:CHESTERCOUNTYEYECARE	COM:NOVARTIS	COM:RETINAI
Market	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services		Healthcare & Health Services
Industry	Medical Services		Healthcare Technology
Country	US	CH	CH
Stage			Series B
Employee Count		101.70K	38
Website	chestercountyeyecare.com	novartis.com	retinai.com
LinkedIn		novartis	retinai
Founders

Metric
Market Cap	220.95B
Enterprise Value
Monthly Web Traffic		9.75K
Web Traffic Growth		0.67
Valuation
Raised Capital		7.80M

Metric
Revenue		46.66B
Revenue (LTM)
Revenue (NTM)
Gross Profit		34.19B
EBITDA		18.47B
Operating Income		9.77B
Net Income		14.85B
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.75
Operating Profit Margin		0.25
EBITDA Margin		0.40
Net Profit Margin		0.33
Return on Equity		0.39
Return on Assets		0.17
Return on Capital Employed		0.17

CHES

COM:CHESTERCOUNTYEYECARE

Chester County Eye Care

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		14.33
P/B Ratio		4.56
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		4.83
EV Multiple		11.29

Metric
Days Sales Outstanding		67.09
Days Payables Outstanding		124.77
Days Inventory Outstanding		169.11
Operating Cycle		232.40
Cash Conversion Cycle		110.44
Asset Turnover		0.53

Metric
Operating Cash Flow		14.46B
Free Cash Flow		11.71B
Cash Flow to Debt		0.55
Operating Cash Flow/Sales		0.31
Free Cash Flow Yield		0.05

Metric
Cash & Equivalents		13.39B
Accounts Receivable		-1.50B
Inventory		5.91B
Goodwill		23.34B
Debt to Capitalization		0.41
Debt to Assets		0.26
Current Ratio		1.16
Quick Ratio		0.88

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.02
R&D to Revenue		0.23
SG&A to Revenue